Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2023; 20(8):1024-1037. doi:10.7150/ijms.85789 This issue Cite

Review

Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms

Zhihua Yang1,2, Yangxi Liu1, Zhihui Song2, Yujian Fan1, Shanshan Lin1, Zhao Ge1, Shaoling Feng1, Yu Liu1, Yingfei Bi1, Yi Wang2✉, Xianliang Wang1✉, Jingyuan Mao1✉

1. First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300381, China.
2. Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.

✉ Corresponding authors: Xianliang Wang: xlwang1981com, Yi Wang: wangyiedu.cn, Jingyuan Mao: jymaocom.

Citation:
Yang Z, Liu Y, Song Z, Fan Y, Lin S, Ge Z, Feng S, Liu Y, Bi Y, Wang Y, Wang X, Mao J. Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms. Int J Med Sci 2023; 20(8):1024-1037. doi:10.7150/ijms.85789. https://www.medsci.org/v20p1024.htm
Other styles

File import instruction

Abstract

Graphic abstract

Coronary microvascular disease (CMVD) is a high risk factor for many cardiovascular events. Due to the limited understanding of its pathophysiological mechanism, modern medicine still lacks therapeutic drugs for CMVD. Existing clinical studies have shown that traditional Chinese medicine (TCM) can effectively improve the clinical symptoms and quality of life of CMVD patients. As an indispensable part of TCM, Chinese patent medicines (CPMs) are widely used in clinical practice. In the face of numerous oral CPMs for treatment of CMVD, how to choose a reasonable medication regimen is one of the important issues in clinic. Based on this, this paper reviewed the clinical efficacy and recommended level of 12 CPMs in the treatment of CMVD, which are recommended by expert consensus on diagnosis and treatment of coronary microvascular disease with integrated Chinese and Western medicine (WM). In addition, this study also systematically summarized the possible mechanisms of CPMs in the treatment of CMVD by protecting coronary microvascular endothelial cells, improving vascular endothelial function, inhibiting inflammation, reducing oxidative stress, promoting angiogenesis, and improving hemorheology, aiming to provide meaningful information for its clinical application.

Keywords: coronary microvascular disease, traditional Chinese medicine, Chinese patent medicines, clinical evidence, potential mechanisms

Citation styles

APA
Yang, Z., Liu, Y., Song, Z., Fan, Y., Lin, S., Ge, Z., Feng, S., Liu, Y., Bi, Y., Wang, Y., Wang, X., Mao, J. (2023). Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms. International Journal of Medical Sciences, 20(8), 1024-1037. https://doi.org/10.7150/ijms.85789.

ACS
Yang, Z.; Liu, Y.; Song, Z.; Fan, Y.; Lin, S.; Ge, Z.; Feng, S.; Liu, Y.; Bi, Y.; Wang, Y.; Wang, X.; Mao, J. Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms. Int. J. Med. Sci. 2023, 20 (8), 1024-1037. DOI: 10.7150/ijms.85789.

NLM
Yang Z, Liu Y, Song Z, Fan Y, Lin S, Ge Z, Feng S, Liu Y, Bi Y, Wang Y, Wang X, Mao J. Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms. Int J Med Sci 2023; 20(8):1024-1037. doi:10.7150/ijms.85789. https://www.medsci.org/v20p1024.htm

CSE
Yang Z, Liu Y, Song Z, Fan Y, Lin S, Ge Z, Feng S, Liu Y, Bi Y, Wang Y, Wang X, Mao J. 2023. Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms. Int J Med Sci. 20(8):1024-1037.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use